LAURA CERVANTES: Open Payments
NPI 1255879698 · ROWLETT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$795 in 14 payments from 7 companies in 2025. Trend: 2023 $2,349 · 2024 $857 · 2025 $795
Food & beverage: $795
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 5 | $375 |
| Astellas Pharma US Inc | 1 | $119 |
| Exeltis, USA Inc. | 1 | $103 |
| Kowa Pharmaceuticals America, Inc. | 1 | $86 |
| ABBVIE INC. | 3 | $49 |
| Lilly USA, LLC | 2 | $39 |
| Abbott Laboratories | 1 | $24 |
Products named: Auvelity, Veozah, TWIRLA, ZORYVE, MOUNJARO, VRAYLAR, FREESTYLE LIBRE 3, QULIPTA.
Industry payments across TX — which companies pay providers there.
